FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382987923> ?p ?o ?g. }

• W4382987923 abstract "<p>Supplemental figures S1-S22: Supplementary Figure S1 shows lipid metabolism dependency in FLT3-mutant AML, Supplementary Figure S2 shows anti-leukemic activity of GILT across a panel of AML PDX, Supplementary Figure S3 shows mechanisms of post-translational regulation of C/EBPα expression, Supplementary Figure S4 shows inhibition of C/EBPα phosphorylation and protein expression by FLT3i, Supplementary Figure S5 shows the implication of Ser-21 phosphorylation in post-translational regulation of C/EBPα expression, Supplementary Figure S6 shows that FLT3-ITD regulates the expression of C/EBPα and of proteins related to lipid biosynthesis in AML cell lines, Supplementary Figure S7 shows that FLT3-ITD regulates the expression of genes related to lipid biosynthesis in AML cell lines, Supplementary Figure S8 shows that C/EBPα directly regulates the transcription of lipid biosynthesis genes in AML, Supplementary Figure S9 shows the correlation between CEBPA mRNA expression and FLT3-ITD mutations, Supplementary Figure S10 shows scRNA-seq analysis from PDXTUH84, Supplementary Figure S11 shows scRNA-seq analysis from PDXTUH110, Supplementary Figure S12 shows the evolution of CEBPA_UP and FLT3-ITD_UP signatures in patients with AML treated with GILT, Supplementary Figure S13 shows that C/EBPα regulates rate-limiting lipid biosynthetic enzymes downstream of FLT3-ITD, Supplementary Figure S14 shows that C/EBPα controls lipid amount in FLT3-ITD cell lines, Supplementary Figure S15 shows that FLT3 inhibitors induce a lipid switch increasing neutral lipids dependent on C/EBPα, Supplementary Figure S16 shows that FLT3 inhibitor inhibits fatty acid synthesis fueled by glucose and glutamine, Supplementary Figure S17 shows that FLT3 inhibition decreases monounsaturated fatty acid dependent on C/EBPα, Supplementary Figure S18 shows that FLT3 inhibition increases PUFA/MUFA ratio dependent on C/EBPα, Supplementary Figure S19 shows that ferroptotic cell death induced by FLT3i is mediated by inhibition of SCD-dependent mono-unsaturated FA synthesis, Supplementary Figure S20 shows that FLT3 inhibitors unmask a vulnerability of FLT3-mutant leukemic cells to ferroptosis, Supplementary Figure S21 shows that lipid redox stress induction by GPX4 inhibition primed FLT3i activity in FLT3-ITD AML cells and Supplementary Figure S22 shows combined treatment with GILT and APR-246 in preclinical AML models in vivo.</p>" @default.
• W4382987923 created "2023-07-04" @default.
• W4382987923 creator A5001412668 @default.
• W4382987923 creator A5003294000 @default.
• W4382987923 creator A5004675476 @default.
• W4382987923 creator A5005299934 @default.
• W4382987923 creator A5005591514 @default.
• W4382987923 creator A5006591827 @default.
• W4382987923 creator A5009603781 @default.
• W4382987923 creator A5010006480 @default.
• W4382987923 creator A5010730760 @default.
• W4382987923 creator A5010847260 @default.
• W4382987923 creator A5014021738 @default.
• W4382987923 creator A5016435003 @default.
• W4382987923 creator A5017187640 @default.
• W4382987923 creator A5018074362 @default.
• W4382987923 creator A5018719838 @default.
• W4382987923 creator A5018919552 @default.
• W4382987923 creator A5021453271 @default.
• W4382987923 creator A5022060862 @default.
• W4382987923 creator A5023548366 @default.
• W4382987923 creator A5023772673 @default.
• W4382987923 creator A5030443147 @default.
• W4382987923 creator A5032477226 @default.
• W4382987923 creator A5033024636 @default.
• W4382987923 creator A5034759187 @default.
• W4382987923 creator A5036699581 @default.
• W4382987923 creator A5037089082 @default.
• W4382987923 creator A5037378188 @default.
• W4382987923 creator A5037383408 @default.
• W4382987923 creator A5038316031 @default.
• W4382987923 creator A5038937943 @default.
• W4382987923 creator A5039797032 @default.
• W4382987923 creator A5041695874 @default.
• W4382987923 creator A5044947156 @default.
• W4382987923 creator A5046308449 @default.
• W4382987923 creator A5046461773 @default.
• W4382987923 creator A5052176584 @default.
• W4382987923 creator A5052531237 @default.
• W4382987923 creator A5053533004 @default.
• W4382987923 creator A5058284453 @default.
• W4382987923 creator A5060566535 @default.
• W4382987923 creator A5063779337 @default.
• W4382987923 creator A5063877554 @default.
• W4382987923 creator A5069894834 @default.
• W4382987923 creator A5073125776 @default.
• W4382987923 creator A5074149966 @default.
• W4382987923 creator A5079805272 @default.
• W4382987923 creator A5082234329 @default.
• W4382987923 creator A5083840321 @default.
• W4382987923 creator A5085576247 @default.
• W4382987923 creator A5085586206 @default.
• W4382987923 creator A5086265821 @default.
• W4382987923 creator A5086774330 @default.
• W4382987923 creator A5087031566 @default.
• W4382987923 creator A5087151365 @default.
• W4382987923 creator A5088104335 @default.
• W4382987923 creator A5090435126 @default.
• W4382987923 creator A5090936220 @default.
• W4382987923 date "2023-07-03" @default.
• W4382987923 modified "2023-10-15" @default.
• W4382987923 title "Supplementary Figures S1-S22 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in <i>FLT3</i>-Mutant Leukemia" @default.
• W4382987923 doi "https://doi.org/10.1158/2159-8290.23618470.v1" @default.
• W4382987923 hasPublicationYear "2023" @default.
• W4382987923 type Work @default.
• W4382987923 citedByCount "0" @default.
• W4382987923 crossrefType "posted-content" @default.
• W4382987923 hasAuthorship W4382987923A5001412668 @default.
• W4382987923 hasAuthorship W4382987923A5003294000 @default.
• W4382987923 hasAuthorship W4382987923A5004675476 @default.
• W4382987923 hasAuthorship W4382987923A5005299934 @default.
• W4382987923 hasAuthorship W4382987923A5005591514 @default.
• W4382987923 hasAuthorship W4382987923A5006591827 @default.
• W4382987923 hasAuthorship W4382987923A5009603781 @default.
• W4382987923 hasAuthorship W4382987923A5010006480 @default.
• W4382987923 hasAuthorship W4382987923A5010730760 @default.
• W4382987923 hasAuthorship W4382987923A5010847260 @default.
• W4382987923 hasAuthorship W4382987923A5014021738 @default.
• W4382987923 hasAuthorship W4382987923A5016435003 @default.
• W4382987923 hasAuthorship W4382987923A5017187640 @default.
• W4382987923 hasAuthorship W4382987923A5018074362 @default.
• W4382987923 hasAuthorship W4382987923A5018719838 @default.
• W4382987923 hasAuthorship W4382987923A5018919552 @default.
• W4382987923 hasAuthorship W4382987923A5021453271 @default.
• W4382987923 hasAuthorship W4382987923A5022060862 @default.
• W4382987923 hasAuthorship W4382987923A5023548366 @default.
• W4382987923 hasAuthorship W4382987923A5023772673 @default.
• W4382987923 hasAuthorship W4382987923A5030443147 @default.
• W4382987923 hasAuthorship W4382987923A5032477226 @default.
• W4382987923 hasAuthorship W4382987923A5033024636 @default.
• W4382987923 hasAuthorship W4382987923A5034759187 @default.
• W4382987923 hasAuthorship W4382987923A5036699581 @default.
• W4382987923 hasAuthorship W4382987923A5037089082 @default.
• W4382987923 hasAuthorship W4382987923A5037378188 @default.
• W4382987923 hasAuthorship W4382987923A5037383408 @default.
• W4382987923 hasAuthorship W4382987923A5038316031 @default.
• W4382987923 hasAuthorship W4382987923A5038937943 @default.
• W4382987923 hasAuthorship W4382987923A5039797032 @default.
• W4382987923 hasAuthorship W4382987923A5041695874 @default.
• W4382987923 hasAuthorship W4382987923A5044947156 @default.

• next